Earnings call Lincoln Pharmaceuticals delivered strong Q3 FY26 results with revenue up 13.6% YoY to INR 166.32 crore and net profit rising 37.7% YoY to INR 28.60 crore. Management reaffirmed its INR 1 ...
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results